IL231070A0 - Estrogen receptor ligands and methods of their use - Google Patents

Estrogen receptor ligands and methods of their use

Info

Publication number
IL231070A0
IL231070A0 IL231070A IL23107014A IL231070A0 IL 231070 A0 IL231070 A0 IL 231070A0 IL 231070 A IL231070 A IL 231070A IL 23107014 A IL23107014 A IL 23107014A IL 231070 A0 IL231070 A0 IL 231070A0
Authority
IL
Israel
Prior art keywords
methods
estrogen receptor
estrogen
receptor
Prior art date
Application number
IL231070A
Other languages
English (en)
Hebrew (he)
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Application filed by Gtx Inc filed Critical Gtx Inc
Publication of IL231070A0 publication Critical patent/IL231070A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IL231070A 2011-08-23 2014-02-20 Estrogen receptor ligands and methods of their use IL231070A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (1)

Publication Number Publication Date
IL231070A0 true IL231070A0 (en) 2014-03-31

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
IL231070A IL231070A0 (en) 2011-08-23 2014-02-20 Estrogen receptor ligands and methods of their use

Country Status (10)

Country Link
EP (1) EP2747562A4 (enrdf_load_stackoverflow)
JP (1) JP2014524479A (enrdf_load_stackoverflow)
KR (1) KR20140064906A (enrdf_load_stackoverflow)
CN (1) CN103957706A (enrdf_load_stackoverflow)
AU (1) AU2012312902B2 (enrdf_load_stackoverflow)
CA (1) CA2845890A1 (enrdf_load_stackoverflow)
IL (1) IL231070A0 (enrdf_load_stackoverflow)
IN (1) IN2014DN01959A (enrdf_load_stackoverflow)
MX (1) MX2014002105A (enrdf_load_stackoverflow)
RU (1) RU2014111060A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018342909B2 (en) * 2017-09-27 2023-06-08 Targimmune Therapeutics Ag Castration resistant prostate cancer
CA3128331C (en) * 2019-01-30 2024-06-18 Margaret K. YU Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer
WO2020157334A1 (en) * 2019-02-01 2020-08-06 Fondazione Per L'istituto Oncologico Di Ricerca (Ior) Methods of treating castrate-resistant prostate cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
EP2455362A1 (en) * 2005-11-28 2012-05-23 GTX, Inc. Nuclear receptor binding agents
KR20130101146A (ko) * 2009-02-23 2013-09-12 지티엑스, 인코포레이티드 에스트로겐 수용체 리간드 및 그 이용 방법

Also Published As

Publication number Publication date
AU2012312902A1 (en) 2013-05-23
KR20140064906A (ko) 2014-05-28
IN2014DN01959A (enrdf_load_stackoverflow) 2015-05-15
CN103957706A (zh) 2014-07-30
JP2014524479A (ja) 2014-09-22
MX2014002105A (es) 2014-09-25
EP2747562A1 (en) 2014-07-02
AU2012312902B2 (en) 2016-03-17
EP2747562A4 (en) 2015-05-06
RU2014111060A (ru) 2015-09-27
CA2845890A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
IL227440B (en) Spherical support device and methods of use
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
EP2791132A4 (en) ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
ZA201403760B (en) Anti-cd98 antibodies and methods of use thereof
IL232055B (en) Anti-1htra antibodies and methods of use
SI2683731T1 (sl) C4-monometil triterpenoidni derivati in postopki njihove uporabe
ZA201307115B (en) Androgen receptor antagonists and uses thereof
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
IL238227A0 (en) Antibodies against c16orf54 and uses thereof
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
ZA201300174B (en) Anti-neuropilin antibodies and methods of use
EP2538780A4 (en) STROGEN RECEPTOR LIGANDS AND METHODS OF USE
EP2709999A4 (en) QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE
IL231070A0 (en) Estrogen receptor ligands and methods of their use
HK1173619A (en) Estrogen receptor ligands and methods of use thereof
GB201216724D0 (en) Note pad and method of use thereof